FIELD: organic chemistry. SUBSTANCE: invention describes inhibitors of process associated with DP-IV taken among compounds of the general formula: A-B (group I) where B means formula (I) ; n = 1 or 2; m = 0, 1 or 2; X means CH2, S, SO, SO2, O; Y means N; R means H, CN, CHO, B(OH)2; A is bound to Y and a) when R means H, then A is alpha-aminoacyl group obtained from alpha-amino acid carrying cycloaliphatic side chain or beta-aminoacyl group of the general formula (II) where p = 1-6 and in any case ring can contain unsaturated bonds and/or substitution with heteroatom; b) when R means CN then A corresponds to definition given in (a) and except for it can be obtained from any L-alpha-amino acid carrying lipophilic side chain and c) when R means CHO or B(OH)2 then A means beta-aminoacyl group determined in (a); (group II): B, n, m, X as indicated above; R means H, CN; A is bound to Y and A means (i) where a = 1-5; D means G-(CH2)b-(R4)-R3; G means NH or NMe; b = 1-12; g = 0 or 1; R4 means Z-NH-(CH2)c or NH-Z-(CH2)c- where c = 1-12; Z means CO, CH2; R3 is CO2H or its ester, CONH2, CONR5R6, SO2NH2, SO2NR5R6, OH, OR5, substituted or unsubstituted aryl, NH2, NR5R6, NHCOR5, NHSO2R5, NH-CH(:NR5)NR5R6; R5 and R6 are taken independently each of other among H, lower alkyl, fluoroalkyl groups or R5 and R6 in common with nitrogen atom to which they are bound form the chain C3-C8 or A means (ii) where R1 is H, Me; E is J-(CH2)b-(R4)q-R3; J is CO; a, b, q, R3 and R4 correspond to definition given in (i); or it means (III) where R2 is H, Me; L means (CH2)d-(CO)r-(CH2)b-(R4)q-R3 where r = 1; d = 1-4; b, q, R3 and R4 correspond to definition given in (i). The above described inhibitors are highly active competitive inhibitors of DP-IV (values K are in the range from 10-6 to 10-10) and they exhibit chemical stability (t1/2 > 24 h). EFFECT: inhibitors indicated above, valuable chemical properties. 4 cl, 8 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
NEW ANTI-DIABETIC AGENTS | 2000 |
|
RU2265012C2 |
BICYCLIC COMPOUNDS AS ALLOSTERIC SHP2 INHIBITORS | 2018 |
|
RU2776846C2 |
GROWTH-STIMULATING COMPOSITION | 2000 |
|
RU2242228C2 |
INHIBITORS OF DIPEPTIDYL-PEPTIDASE IV | 2001 |
|
RU2283303C2 |
PHOSPHOINDOLES AS HIV INHIBITORS | 2005 |
|
RU2393163C2 |
BETA-LACTAMASE INHIBITORS | 2009 |
|
RU2445314C9 |
PYRIMIDINE DERIVATIVES USED AS PROTEIN KINASE INHIBITORS | 2008 |
|
RU2478100C2 |
NON-PEPTIDE ANTAGONISTS GnRH | 2003 |
|
RU2329251C2 |
ROR-GAMMA MODULATORS | 2012 |
|
RU2658013C2 |
N-7 SUBSTITUTED PURINES AND PYRAZOLOPYRIMIDINES, COMPOSITIONS THEREOF AND METHODS FOR USE | 2010 |
|
RU2515541C2 |
Authors
Dates
2000-09-20—Published
1994-11-30—Filed